Project Grant HT94252410774
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,047,751 Project Grant to the Portland VA Research Foundation, Inc. to conduct the "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE" research project. This 4-year award, beginning on Sep 1, 2024 and ending on Aug 31, 2028, will enable the Portland VA Research Foundation to carry out scientific research aimed at improving health outcomes for...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $999,823 Project Grant to Oregon Health & Science University (OHSU) on June 1, 2024. The grant, titled "TARGETING NEURODEGENERATION IN THE AGED DEMYELINATED CNS," supports OHSU's biomedical research efforts to investigate innovative treatments for neurological disorders. Through this funding, OHSU will conduct basic, applied, and advanced research to develop new medical...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $674,746 Project Grant to the Seattle Institute for Biomedical and Clinical Research. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE", aims to investigate glymphatic function and sleep disruption in Parkinson's disease. The research will leverage expertise and resources from the University of Washington, where a $214,688 sub-award...
The Oregon Health & Science University (OHSU) was awarded a $644,570 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund the TBI Exosomal Activity in Military Personnel: Perivascular Space and Role of Indicators of Sleep Metrics (TEAM-PRISM) project. Through this funding, OHSU researchers will investigate medical solutions for traumatic brain injury on the battlefield by exploring the role...
The Oregon Health & Science University was awarded a $249,308 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2021 through March 31, 2024. The grant aims to support research titled "IANAM: THE ABILITY TO "VISUALIZE" HEADACHE, SLEEP DISTURBANCE, AND MTBI" which investigates medical solutions for conditions experienced by military service members, such as traumatic brain...
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...
The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these...
Oregon Health & Science University was awarded a $494,340 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
Oregon Health & Science University was awarded a $506,554 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. Through basic, applied, and advanced biomedical research supported by this program, the Army aims to transform military and public health care by...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...